English | Español
Jeff Gantt | Dec 24, 2016

Pfizer releases Paloma-2 sub-analysis study data
Jeff Gantt | Dec 24, 2016

European Commission approves Nimenrix for meningococcal disease
Keri Carbaugh | Dec 24, 2016

Pfizer’s Ibrance application accepted by FDA
Keri Carbaugh | Dec 24, 2016

Sucampo proposes making convertible senior notes available
Jeff Gantt | Dec 24, 2016

EMA recommends Keytruda for approval
Jeff Gantt | Dec 23, 2016

Keytruda approved in Japan to treat lung cancer
Jeff Gantt | Dec 23, 2016

Food and Drug Administration gives approval to Synjardy XR tablets
Ruth de Jauregui | Dec 23, 2016

DNA vaccine for peanut allergy fast-tracked

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’